Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV001418272 | SCV001620497 | likely benign | Naxos disease; Arrhythmogenic right ventricular dysplasia 12 | 2025-01-23 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV004994077 | SCV005601712 | likely benign | Cardiovascular phenotype | 2024-10-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Prevention |
RCV003938243 | SCV004748003 | likely benign | JUP-related disorder | 2019-03-08 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |